Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 14/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 12/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL5643862 | 0.94 | ESR1 (0.43) | ESR1ESR2GRIN2B | |
| SCHEMBL5115815 | 0.93 | ESR1 (0.54) | ESR1ESR2LTA4HGRIN2B | |
| SCHEMBL5105667 | 0.89 | ESR1 (0.48) | ESR1ESR2LTA4HGRIN2B | |
| SCHEMBL5643856 | 0.89 | ESR1 (0.36) | ESR1ESR2LTA4H | |
| Trifluoroacetic Acid SCHEMBL5106301 | 0.89 | ESR1 (0.49) | ESR1ESR2GRIN2B | |
| SCHEMBL5641422 | 0.87 | ESR1 (0.43) | ESR1ESR2LTA4HGRIN2B | |
| SCHEMBL5108803 | 0.87 | ESR1 (0.49) | ESR1ESR2GRIN2B | |
| SCHEMBL7813313 | 0.87 | ESR1 (0.45) | ESR1ESR2GRIN2B | |
| SCHEMBL5102726 | 0.86 | ESR1 (0.46) | ESR1ESR2 | |
| SCHEMBL5115570 | 0.85 | KDM4E (0.48) | ESR1ESR2GRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7435729-B2 | Compounds and methods for modulation of estrogen receptors | SIGNAL PHARMACEUTICALS, LLC (US) | 2008-10-14 | — | — | US | disclosed |
| EP-1322617-A1 | COMPOUNDS AND METHODS FOR MODULATION OF ESTROGEN RECEPTORS | SIGNAL PHARMACEUTICALS, INC. (US) | 2003-07-02 | — | — | EP | disclosed |
| WO-2002024653-A1 | COMPOUNDS AND METHODS FOR MODULATION OF ESTROGEN RECEPTORS | SIGNAL PHARMACEUTICALS, INC. (US) | 2002-03-28 | — | — | WO | disclosed |